Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Viking Therapeutics, Inc.
organization3 mentionslast seen Oct 5, 2026
Clinical-stage biopharmaceutical company developing therapies for obesity and metabolic disease.
Relationships 6
- Viking Therapeutics, Inc.employsBrian Lian99% confidence2 sources
- Viking Therapeutics, Inc.developsVK273595% confidence1 source
- Viking Therapeutics, Inc.developsVK301992% confidence1 source
- Viking Therapeutics, Inc.developsVK021492% confidence1 source
- Viking Therapeutics, Inc.developsVK280992% confidence1 source
- Viking Therapeutics, Inc.developsViking Mira85% confidence1 source
Relationship
Viking Therapeutics, Inc.employsBrian Lian
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARSep 28, 2026Viking Therapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Item 9.01: Financial Statements and Exhibits
By: /s/ Brian Lian, Ph.D. President and Chief Executive Officer (Principal Executive Officer)
- filingSEC EDGARSep 22, 2026Viking Therapeutics, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Brian Lian, Ph.D. President and Chief Executive Officer (Principal Executive Officer)